Coherus Oncology (CHRS) Exchange Rate Effect (2014 - 2019)
Coherus Oncology's (CHRS) quarterly Exchange Rate Effect came in at -$106000.0 in Q4 2019, down 176.81% year-on-year from $138000.0 in Q4 2018, and down 279.66% quarter-over-quarter from $59000.0 in Q3 2019.
Coherus Oncology (CHRS) Exchange Rate Effect (2014 - 2019) Analysis & Trends
Coherus Oncology has disclosed Exchange Rate Effect across 6 years of filings, most recently posting -$106000.0 for Q4 2019.
- Exchange Rate Effect for Q4 2019 came in at -$106000.0, down 176.81% year-over-year; the trailing twelve-month figure through Mar 2020 was -$140000.0 (down 140.58% YoY), and the FY2019 annual result was -$276000.0, down 158.97% from the prior year.
- Exchange Rate Effect came in at -$106000.0 for Q4 2019 at Coherus Oncology, down from $59000.0 in the prior quarter.
- In the past five years, Exchange Rate Effect ranged from a high of $226000.0 in Q2 2018 to a low of -$271000.0 in Q4 2016.
- The 5-year median for Exchange Rate Effect is -$28000.0 (2015), against an average of -$12100.0.
- Across the five-year window, Exchange Rate Effect jumped 2071.43% in 2018 and sank 946.15% in 2019, its largest moves.
- Coherus Oncology's Exchange Rate Effect stood at $82000.0 in 2015, then plunged by 430.49% to -$271000.0 in 2016, then surged by 97.42% to -$7000.0 in 2017, then surged by 2071.43% to $138000.0 in 2018, then plunged by 176.81% to -$106000.0 in 2019.
- The last three Exchange Rate Effect figures came in at -$106000.0 (Q4 2019), $59000.0 (Q3 2019), and -$93000.0 (Q2 2019), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Exchange Rate Effect (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 3.60 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | -2.70 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | -40.30 Mn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | 8.68 Mn |
| 10 | Coherus Oncology | 199.14 Mn | 32.09 Mn | 8.50 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2019 | -106,000.00 |
| Dec 31, 2019 | -106,000.00 |
| Sep 30, 2019 | 59,000.00 |
| Sep 30, 2019 | 59,000.00 |
| Jun 30, 2019 | -93,000.00 |
| Jun 30, 2019 | -93,000.00 |
| Mar 31, 2019 | -136,000.00 |
| Mar 31, 2019 | -136,000.00 |
| Dec 31, 2018 | 138,000.00 |
| Dec 31, 2018 | 138,000.00 |
| Sep 30, 2018 | 117,000.00 |
| Sep 30, 2018 | 117,000.00 |
| Jun 30, 2018 | 226,000.00 |
| Jun 30, 2018 | 226,000.00 |
| Mar 31, 2018 | -13,000.00 |
| Mar 31, 2018 | -13,000.00 |
| Dec 31, 2017 | -7,000.00 |
| Dec 31, 2017 | -7,000.00 |
| Sep 30, 2017 | -70,000.00 |
| Sep 30, 2017 | -70,000.00 |